Holders — by stockHoldings — by fund
ACORN CAPITAL ADVISORS, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002054410
$364.0M
disclosed book value
22
positions
22%
largest position share
Positions, as of 2026-09-30
top 22 of 22 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1.1M | $80.2M | 22% |
| 2 | URGNUROGEN PHARMA LTD | 1.6M | $67.0M | 18.4% |
| 3 | PBYIPUMA BIOTECHNOLOGY INC | 4.1M | $41.0M | 11.3% |
| 4 | CADLCANDEL THERAPEUTICS INC | 3.5M | $36.5M | 10% |
| 5 | TRVITREVI THERAPEUTICS INC | 2.1M | $30.7M | 8.4% |
| 6 | HELPHELUS PHARMA INC. | 1.5M | $18.9M | 5.2% |
| 7 | JBIOJADE BIOSCEINCES INC | 986,760 | $13.9M | 3.8% |
| 8 | BCAXBICARA THERAPEUTICS | 668,381 | $12.4M | 3.4% |
| 9 | VSTMVERASTEM INC | 1.5M | $11.8M | 3.2% |
| 10 | OKURONKURE THERAPEUTICS INC | 2.8M | $7.8M | 2.1% |
| 11 | ENGNEUGENE THERAPEUTICS | 3.8M | $7.6M | 2.1% |
| 12 | ANTXAN2 THERAPEUTICS | 1.3M | $6.9M | 1.9% |
| 13 | AURAAURA BIOSCIENCES INC | 1.0M | $6.4M | 1.8% |
| 14 | TARAPROTARA THERAPEUTICS INC | 1.8M | $5.3M | 1.5% |
| 15 | ANNXANNEXON INC. | 1.1M | $4.8M | 1.3% |
| 16 | LONALEONABIO, INC. | 1.1M | $4.1M | 1.1% |
| 17 | WHWKWHITEHAWK THERAPEUTICS INC | 932,139 | $3.5M | 1% |
| 18 | QTTBQ32 BIO INC. | 216,171 | $1.8M | 0.5% |
| 19 | KPTIKARYOPHARM THERAPEUTICS INC | 1.2M | $1.5M | 0.4% |
| 20 | JSPRJASPER THERAPEUTICS | 1.4M | $834,132 | 0.2% |
| 21 | MNLOUSDYARROW BIOSCIENCES INC | 32,005 | $720,744 | 0.2% |
| 22 | BCABGBPBIOATLA INC | 108,127 | $140,565 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.